Other Listings. BioNumerik will use Commercially Diligent Efforts to register the Product in specified United States compendial listings with prior consultation from Takeda.
Appears in 2 contracts
Sources: License and Development Alliance Agreement (BioNumerik Pharmaceuticals, Inc.), License and Development Alliance Agreement (BioNumerik Pharmaceuticals, Inc.)